Vaxart announced positive preclinical data for ioral COVID-19 vaccine program
On Apr. 21, 2020, Vaxart announced it had obtained positive pre-clinical results for its COVID-19 vaccine candidates, with…
On Apr. 21, 2020, Vaxart announced it had obtained positive pre-clinical results for its COVID-19 vaccine candidates, with…
On Apr. 21, 2020, aTyr Pharma announced the FDA has accepted its Investigational New Drug application to evaluate…
On Apr. 21, 2020, OpGen announced the start of an investigator initiated collaboration with Karolinska Institutet, Sweden, to…
On Apr. 21, 2020, LabCorpᆴ announced it has received an Emergency Use Authorization (EUA) from the FDA. The…
On Apr. 21, 2020, Quest Diagnostics announced that it has begun to perform antibody testing for coronavirus (COVID-19)…
On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers UniversityヨCamden research laboratory, where chemistry…
On Apr. 20, 2020, VGX signed as the first occupant of Conroeメs Deison Technology Park and will move…
On Apr. 20, 2020, Atossa Therapeutics announced that it had applied to the FDA for approval to commence…
On Apr. 20, 2020, Alexion announced plans to initiate a global Phase 3 study to investigate ULTOMIRISᆴ (ravulizumab-cwvz)…
On Apr. 20, 2020, Innovation Pharma reported that based on molecular screening of 11,552 compounds comprising already FDA-approved…
On Apr. 17, 2020, the NIH and the Foundation for the NIH are bringing together more than a…
On Apr. 17, 2020, Emory University announced it had begun enrolling adults over age 55 in the clinical…
On Apr. 16, 2020, Regeneron announced the FDA has accepted for Priority Review a new Biologics License Application…
On Apr. 16, 2020, Atossa Therapeutics announced a new drug development program called COVID-19 HOPE. The program used…
On Apr. 16, 2020, Dynavax and Sinovac Biotech, a leading provider of biopharmaceutical products in China, announced a…
On Apr. 16, 2020, Scripps Research announced that researchers at Calibr, Scripp’s drug development division, had established an…
On Apr. 16, 2020, Pulmatrix announced a collaboration and license agreement with Sensory Cloud. Under the terms of…
On Apr. 16, 2020, CHF Solutions announced increased utilization of its Aquadex therapy in patients affected by COVID-19….
On Apr. 16, 2020, Soligenix announced it has executed an agreement for the exclusive worldwide license of CoVaccine…
On Apr. 15, 2020, Queensland University of Technology (QUT) reported it had developed and tested a highly breathable…
On Apr. 15, 2020, Accelerate Diagnostics announced they have entered into a commercial supply and collaboration agreement. Under…
On Apr. 15, 2020, Humanigen announced that U.S. Food and Drug Administration (FDA) had given permission to commence…
On Apr. 15, 2020, Royal Philips and UK HealthCare, the clinical enterprise of the University of Kentucky, announced…
On Apr. 15, 2020, the U.S. Food and Drug Administration (FDA) authorized the production and use of a…
On Apr. 15, 2020, the FDA announced it granted Emergency Use Authorization to Ortho Clinical Diagnosticsメ total antibody…
On Apr. 15, 2020, Abbott announced the launch of its third COVID-19 test, a lab-based serology blood test…
On Apr. 15, 2020, Vanda Pharma and Northwell Health’s research arm, The Feinstein Institutes for Medical Research, announced…
On Apr. 15, 2020, Chembio Diagnostics announced receipt of FDA Emergency Use Authorization (EUA) for its DPP COVID-19…
On Apr. 15, 2020, HALIX announced it had joined a consortium of partners under the guidance of the…
On Apr. 15, 2020, Getinge announced support of the Ventilator Manufacturers Group to form Ventilator Training Alliance (VTA)…